Taiwan FDA registration 45b81b04864d9495de6e55164de4f094
"CJ" A/B Influenza Rapid Test (Non-sterile)
TW: "啟哲"A/B型流行性感冒病毒快速檢驗試劑 (未滅菌)
Taiwan·Risk Class 1·MD·Qizhe Biotechnology Co., Ltd·Registered Feb 20, 2019 – Feb 20, 2024ExpiredRegistration details
- Analysis ID
- 45b81b04864d9495de6e55164de4f094
- License Form
- Ministry of Health Medical Device Manufacturing No. 007656
Company information
- Manufacturer
- Qizhe Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qizhe Biotechnology Co., Ltd
Product details
- Intended Use
- Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C3330 Influenza virus serum reagent
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Feb 20, 2019
- Expiry Date
- Feb 20, 2024
About this record
Access comprehensive regulatory information for "CJ" A/B Influenza Rapid Test (Non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 45b81b04864d9495de6e55164de4f094 and manufactured by Qizhe Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices